Abstract
Sarcopenia is recognized as a major health problem among older adults. This syndrome is associated with serious health consequences in terms of frailty, disability, morbidity and mortality. The aim of this study is to review sarcopenia and its impact on quality of life (QoL). MEDLINE database was searched from January to March 2016 using predefined search terms “sarcopenia”, quality of life”. Based on extensive literature search, 32 articles were identified while only 6 studies met the inclusion criteria and were associated with sarcopenia and QoL. Quality of life level was measured using generic self-reported tools; the Medical Outcomes Survey Short-form General Health Survey (SF-36) in 4 studies and EuroQol-5D instrument (EQ-5D) in 2 studies. Subjects with sarcopenia demonstrated a significantly high proportion of problems relating to several dimensions of QoL. More studies based on Sarcopenia and QoL are needed. Although the impact of sarcopenia on QoL was assessed in all studies with QoL generic instruments, it would be more insightful to utilise a disease-specific quality of life questionnaire, such as the SarQoL for sarcopenic subjects.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Von Haeling, S., J.E. Morley, and S.D. Anker. 2010. An Overview of Sarcopenia: Facts and Numbers on Prevalence and Clinical Impact. Journal of Cachexia, Sarcopenia and Muscle 1: 129–133.
Rosenberg, I.H. 1997. Sarcopenia: Origins and Clinical Relevance. The Journal of Nutrition 127: 990S–991S.
Morley, J.E. 2008. Sarcopenia: Diagnosis and Treatment. The Journal of Nutrition, Health & Aging 12: 452–456.
Rizzoli, R., J.Y. Reginster, J.F. Arnal, I. Bautmans, C. Beuadart, H. Bischoff-Ferrari, et al. 2013. Quality of Life in Sarcopenia and Frailty. Calcified Tissue International 93: 101–120.
Cruz-Jentoft, A.J., J.P. Baeyens, J.M. Baur, Y. Boirie, T. Cederholm, F. Landi, et al. 2010. Sarcopenia: European Consensus on Definition and Diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age and Ageing 39: 412–423.
Cruz-Jentoft, A.J., F. Landi, S.M. Schneider, C. Zuniga, H. Arai, Y. Boirie, and L.K. Chen. 2014. Prevalence of and Interventions for Sarcopenia in Ageing Adults: A Systematic Review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age and Ageing 43: 748–759.
Bijma, A.Y., C.G.M. Meskers, N. Van Den Eshof, R.G. Westendrop, S. Sipila, L. Strenroth, et al. 2014. Diagnostic Criteria for Sarcopenia and Physical Performance. AGE 36: 275–285.
Pongchaoiyakul, C., P. Limpawattana, P. Kotruchin, and R. Rajatanavin. 2013. Prevalence of Sarcopenia and Associated Factors Among Thai Population. Journal of Bone and Mineral Metabolism 31: 346–350.
Beaudart, C., J.Y. Reginster, J. Petermanns, S. Gillain, A. Quabron, M. Locquet, J. Slomian, F. Buckinx, and O. Bryuere. 2015. Quality of Life and Physical Components Linked to Sarcopenia: The SarchPhAge Study. Experimental Gerontology 69: 103–110.
Patel, H.P., H.E. Syddall, K. Jameson, S. Robinson, H. Denison, H.C. Roberts, et al. 2013. Prevalence of Sarcopenia in Community-Dwelling Older People in the UK Using the European Working Group on Sarcopenia in Older People (EWGSOP) Definition: Findings from the Hertfordshire Cohort Study (HCS). Age and Ageing 42 (3): 378–384.
Go, S.W., Y.H. Cha, J.A. Lee, et al. 2013. Association Between Sarcopenia, Bone Density, and Health-Related Quality of Life in Korean Men. Korean Journal of Family Medicine 34: 281–288.
Silva Neto, L.S., M.G. Karnikowiski, A.B. Tavares, et al. 2012. Association Between Sarcopenia, Sarcopenic Obesity, Muscle Strength and Quality of Life Variables in Elderly Women. Revista Brasileira de Fisioterapia 16: 360–367.
Sayer, A.A., H.E. Syddall, H.J. Martin, E.M. Dennison, H.C. Roberts, and C. Cooper. 2006. Is Grip Strength Associated with Health-Related Quality of Life? Findings from the Hertfordshire Cohort Study. Age and Ageing 35 (4): 409–415.
Kull, M., R. Kallikorm, and M. Lember. 2012. Impact of a New Sarco-Osteopenia Definition on Health-Related Quality of Life in a Population-Based Cohort in Northern Europe. Journal of Clinical Densitometry 15 (1): 32–38.
Visser, M., D.J.H. Deeg, and P. Lips. 2004. Low Vitamin D and High Parathyroid Hormone Levels as Determinants of Loss of Muscle Strength and Muscle Mass (Sarcopenia): The Longitudinal Aging Study Amsterdam. The Journal of Clinical Endocrinology & Metabolism 88 (12): 5766–5772.
Sayer, A.A., S.M. Robinson, H.P. Patel, T. Shavlakadze, C. Cooper, and M.D. Grounds. 2013. New Horizons in the Pathogenesis, Diagnosis and Management of Sarcopenia. Age and Ageing 42: 145–150.
Beaudart, C., R. Rizzoli, O. Bruyere, J.Y. Regintsre, and E. Biver. 2014. Sarcopenia: Burden and Challenges for Public Health. Archives of Public Health 72: 45.
Higginson, I.J., and A.J. Carr. 2001. Measuring Quality of Life: Using Quality of Life Measures in the Clinical Setting. BMJ 322 (7297): 1297–1300.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this paper
Cite this paper
Tsekoura, M., Kastrinis, A., Katsoulaki, M., Billis, E., Gliatis, J. (2017). Sarcopenia and Its Impact on Quality of Life. In: Vlamos, P. (eds) GeNeDis 2016. Advances in Experimental Medicine and Biology, vol 987. Springer, Cham. https://doi.org/10.1007/978-3-319-57379-3_19
Download citation
DOI: https://doi.org/10.1007/978-3-319-57379-3_19
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-57378-6
Online ISBN: 978-3-319-57379-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)